
Not quite specialty, not quite retail: Cost-effective access and support strategies for a growing, yet underserved, treatment market
Not quite specialty, not quite retail: Cost-effective access and support strategies for a growing, yet underserved, treatment market
The patient-first, pharmacy-first hub model optimizes outcomes and improves care journey for patients with rare disease
Disruption is the order of the day to create a more individual-centric hub experience from the patient’s point of view
A conversation with Ian Riches, head of patient solutions for Europe, Ashfield Engage
The need for supporting services in copay accumulator and best price areas
Creating positive experiences and other patient-focused strategies for sponsors to consider when planning and executing cancer studies
It's time to include hubs in the patient treatment journey
To unlock the full potential of new patient support tools, pharma companies must recognize the crucial role advanced analytics plays in facilitating enhanced patient engagement that yields improved adherence.
Aims to increase presence in affordability market
Taking advantage of new advances in tech-driven engagement to boost patient support and adherence
Finding new efficiencies, managing revenue and changing the dialogue on drug pricing
The services leverage technology to speed planning, budgeting and outsourcing
Rising tide of specialties lifts most providers’ businesses
Connectivity with patients drives pharma growth
Comprehensive patient care becomes the unifying theme of pharma hubs
Personality assessments identify the traits that enable some pharma researchers to ascend to leadership roles in industry
Industry is falling in love with the Apple iPad. Is it the right move for your company?
Today’s uncertain work environment obliges you to manage your career and financial status to keep your options open
Latest 10-year BLS projection sees moderate growth in US employment—except for ‘top executives’
Conventional training of sales forces is being complemented by executive-level training for corporate compliance
BIOPHARMA MANUFACTURING